Galectin Therapeutics (GALT) Convertible Debt (2021 - 2026)
Galectin Therapeutics' Convertible Debt came in at $32.88 million for Q1 2026, up 204.1% from $10.81 million a year earlier and up 0.5% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Convertible Debt (2021 - 2026) Analysis & Trends
At the end of FY2025, Galectin Therapeutics' Convertible Debt was $32.7 million, up 204.7% from FY2024.
- Convertible Debt carries a four-year compound annual growth rate of 3.0% (FY2021 to FY2025).
- Going back by year, Convertible Debt was $10.73 million in FY2024 (-65.3%), $30.9 million in FY2023 (+3.1%), $29.96 million in FY2022 (+3.2%) and $29.05 million in FY2021.
- The Q1 2026 figure represents the highest quarterly Convertible Debt in data going back to Q2 2021.
- Year-over-year, Convertible Debt increased in four of the last seven quarters, with growth averaging 36.2%.
- The fastest year-over-year change in Convertible Debt over five years came in Q2 2022 (growth of 206.0%), and the weakest in Q1 2025 (a decline of 65.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn |
| 10 | Galectin Therapeutics | 222.66 Mn | 166.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 32.88 Mn |
| Dec 31, 2025 | 32.70 Mn |
| Jun 30, 2025 | 32.31 Mn |
| Mar 31, 2025 | 10.81 Mn |
| Dec 31, 2024 | 10.73 Mn |
| Sep 30, 2024 | 21.09 Mn |
| Jun 30, 2024 | 31.38 Mn |
| Mar 31, 2024 | 31.14 Mn |
| Dec 31, 2023 | 30.90 Mn |
| Sep 30, 2023 | 30.67 Mn |
| Jun 30, 2023 | 30.43 Mn |
| Mar 31, 2023 | 30.20 Mn |
| Dec 31, 2022 | 29.96 Mn |
| Sep 30, 2022 | 29.73 Mn |
| Jun 30, 2022 | 29.50 Mn |
| Mar 31, 2022 | 29.28 Mn |
| Dec 31, 2021 | 29.05 Mn |
| Sep 30, 2021 | 19.30 Mn |
| Jun 30, 2021 | 9.64 Mn |
API Access
Galectin Therapeutics Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();